免疫基因组精密医学:基于免疫基因组癌症演变的个性化方法
Yusaku Momoi1,2, Shogo Kumagai1, Hiroyoshi Nishikawa1,3,4,5
1Division of Cancer Immunology, Research Institute/Exploratory Oncology Research & Clinical Trial Center (EPOC), National Cancer Center, Tokyo 104-0045/Chiba 277-8577, Japan.
International immunology
|March 29, 2025
概括
癌症通过多样化和免疫系统选择而发展. 一个新的概念,免疫基因组癌症进化,解释了非炎症性癌症,并指导了个性化的免疫基因组癌症精确医学.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 遗传学 是一个遗传学.
背景情况:
- 癌症的进展是通过进化理论的镜头来看待的,涉及多样化和选择.
- 免疫系统通过癌症免疫编辑假说显著影响癌症的发展.
- 这种假设解释了免疫逃避如何导致临床上明显的癌症,特别是炎症类型.
研究的目的:
- 解决目前癌症免疫编辑假设在解释非炎症性癌症方面的局限性.
- 引入一个新的概念",免疫基因组癌症进化",来描述癌症和免疫系统的共同进化.
- 探索个性化免疫基因组癌症精准医学的潜力.
主要方法:
- 对最近关于人类癌症的研究进行审查,重点关注非炎症类型.
- 对癌细胞的基因组和表观基因组变化的分析.
- 检查免疫抑制机制和瘤原体信号通路.
主要成果:
- 非炎症性癌症可以在初始转化时具有免疫抑制机制,挑战顺序免疫编辑模型.
- 癌细胞和免疫系统的共同进化对于临床上明显的癌症发展至关重要.
- 向瘤信号可以增强抗瘤免疫力,表明治疗潜力.
结论:
- "免疫基因组癌症进化"的概念为了解各种癌症发展途径提供了一个框架.
- 个性化免疫基因组癌症精准医学通过将基因组洞察与免疫调节策略相结合,具有前景.
- 需要进一步的研究,以充分阐明癌症基因组学与免疫系统之间的相互作用,以实现治疗进步.
相关概念视频
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...